GEC-ESTRO Urology: Hathal Haddad Highlights Updates on Urological Cancer Brachytherapy
Hathal Haddad, Head of Interventional Radiotherapy Unit of the Department of Radiation Oncology at Tübingen University Hospital, shared a post on LinkedIn by GEC ESTRO Urology, adding:
“Follow the GEC-ESTRO Urology (UroGec) for the update of brachytherapy for urological cancers (prostate, bladder, penile).”
Quoting GEC ESTRO Urology, adding:
“UroGEC – Advancing Urological Brachytherapy in Europe.
UroGEC is a dedicated group of experts across Europe focusing on the clinical and scientific aspects of brachytherapy for urological cancers, including prostate, bladder, and penile cancer.
We strive to enhance treatment outcomes through collaboration, research, and innovation in interventional radiation oncology.
Stay connected and learn more about our work:
More posts featuring Hathal Haddad.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023